Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMK9BRV)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Pgt-1A; 117241-40-4; 3-Pyroglutamylthiazolidine-4-carboxylic acid; 3-(5-oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid; NSC678119; 3-((5-Oxo-2-pyrrolidinyl)carbonyl)-4-thiazolidinecarboxylic acid; 3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid; 4-Thiazolidinecarboxylic acid, 3-((5-oxo-2-pyrrolidinyl)carbonyl)-; C9H12N2O4S; 3-(5-oxoprolyl)-1,3-thiazolidine-4-carboxylic acid; ACMC-20emtr; ACMC-209vwo; AC1L3FWE; MLS006011471; SCHEMBL9342892; CTK0H7615; MolPort-004-328-744; 4-Thiazolidinecarboxylicacid, 3-[[(2S)-5-
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Cervix
Cervical adenocarcinoma
Colon
Colorectal adenocarcinoma
Kidney
Normal (Immortalized)
Lung
Lung adenocarcinoma
Pancreas
Pancreatic carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
